Outset Medical, Inc.
OM
$3.53
$0.051.44%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 119.48M | 120.07M | 119.30M | 115.27M | 113.69M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 119.48M | 120.07M | 119.30M | 115.27M | 113.69M |
| Cost of Revenue | 72.72M | 74.75M | 75.76M | 73.81M | 74.77M |
| Gross Profit | 46.75M | 45.32M | 43.55M | 41.46M | 38.92M |
| SG&A Expenses | 92.27M | 91.67M | 95.16M | 102.53M | 111.54M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 186.19M | 189.61M | 196.87M | 206.74M | 222.70M |
| Operating Income | -66.71M | -69.54M | -77.57M | -91.46M | -109.01M |
| Income Before Tax | -80.94M | -87.18M | -97.51M | -113.37M | -127.49M |
| Income Tax Expenses | 718.00K | 619.00K | 397.00K | 444.00K | 491.00K |
| Earnings from Continuing Operations | -81.65 | -87.80 | -97.90 | -113.82 | -127.98 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -81.65M | -87.80M | -97.90M | -113.82M | -127.98M |
| EBIT | -66.71M | -69.54M | -77.57M | -91.46M | -109.01M |
| EBITDA | -62.37M | -64.67M | -72.32M | -85.90M | -103.29M |
| EPS Basic | -6.81 | -13.00 | -20.02 | -28.94 | -37.05 |
| Normalized Basic EPS | -3.54 | -7.17 | -11.53 | -17.09 | -22.27 |
| EPS Diluted | -6.81 | -13.00 | -20.02 | -28.94 | -37.05 |
| Normalized Diluted EPS | -3.54 | -7.17 | -11.53 | -17.09 | -22.27 |
| Average Basic Shares Outstanding | 60.38M | 46.08M | 31.78M | 17.50M | 13.85M |
| Average Diluted Shares Outstanding | 60.38M | 46.08M | 31.78M | 17.50M | 13.85M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |